Natura audit, risk and finance committee backs 2Q26 financial statements for board approval
NTCO•Committee backs interim financial statements
- Natura’s audit, risk management, and finance committee met July 31, 2026 to review the company’s Q2 2026 interim financial statements.
- The committee backed the individual and consolidated quarterly information for the three months ended June 30, 2026, with no reservations.
- It also endorsed the accompanying notes and the draft external auditors’ report.
- The committee will recommend that the board approve the Q2 2026 quarterly information.
Related News
Brookfield, Nvidia partner on AI compute financing platform targeting $500 billion capital mobilization
BAM•
Brief-Cogent Biosciences - May Offer Up To $400 Million In Common Stock Through Guggenheim Securities
COGT•
